Delivery Order SPE2DB22D3009-SPE2DB24FAZ51
Award Date
6/28/24
Potential Completion Date
7/1/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,430.52 firm fixed-price contract provides for the delivery of Ketorolac 30 mg/mL vials, a pain medication, to support military and federal medical programs. The award is a delivery order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,351.13 firm fixed-price delivery order is for the supply of ketorolac 30 mg/ml vial, a pain management medication. The contract, which does not have a set-aside designation, has an ultimate completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,939.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4568105691 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed-price pricing type and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This federal contract award to AmerisourceBergen Drug Corp (Corporate Office Division) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,124.88 firm-fixed-price delivery order is for the supply of 4565518698 - Ketorolac 30 mg/ml vial, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with a potential value up to $999,999,999, which enables DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,265.84 firm-fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a critical care medication. The award has an ultimate completion date of August 27, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 30 mg/ml vials. The contract has a total ceiling value of $1,344.56 and a completion date of February 3, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,607.40. The order is for the supply of KETOROLAC 30 MG/ML VIALML, a medication, to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,872.20 for the supply of Ketorolac 30 mg/mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and expiring in December 2026. This IDC serves...
This federal contract award, valued at $1,551.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,174,071 units of the drug Ketorolac 30 mg/ml, a pain medication, with a performance period extending through May 8, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant...